Project

UGent Burkholderia collection as a source of novel antibiotic compounds for the treatment of infections caused by multidrug resistant Gram-negative pathogens

Acronym
BurkAb2
Duration
01 January 2018 → 31 December 2018
Funding
Regional and community funding: Industrial Research Fund
Research disciplines
  • Medical and health sciences
    • Immunology
    • Immunology
    • Microbiology
    • Immunology
Keywords
novel antibiotics Burkholderia antimicrobial resistance Gram-negative bacterial pathogens
 
Project description

Our ultimate goal is to discover at least one new antibiotic class and to draft at least one partnership agreement with a leading public-private partnership on antibiotic resistance. The new compound (s) is (are) preferably oriented towards the market of hospital infections and should (and), to have an immediate market value, preferably be used for the treatment of hospital-acquired pneumonia, urinary tract infections, postoperative wound infections and / or bloodstream infections.